Equity · Healthcare
ALDX
Aldeyra Therapeutics, Inc. · NasdaqCM
The line runs $2 on 24 June through $1.35 on 18 September, on a scale from $1.0 to $2.5. Days the market did not trade hold the previous close, flat.
The chart above plots the price of ALDX over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 61 sessions over that window: $2 on 24 June 2026 through $1.35 on 18 September 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Sep 21, 2026
Filings 4 sets
ALDX reported financials
ALDX reported net income of −$33.8M for the fiscal year ended 31 Dec 2025.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
ALDX earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
ALDX institutional holders
9 of the 45 institutional funds we track reported a ALDX position for the quarter ended 30 Jun 2026 — a combined $19.7M; the latest of those filings landed 02 Sep 2026.
Source: SEC EDGAR 13F filings
ALDX fails-to-deliver
On 31 Aug 2026, 3,850 shares of ALDX failed to deliver (about $6K) — the latest of at least 16 consecutive trading days with recorded fails. The run reaches the start of the window we read, so it may have begun earlier. (latest 14 settlement dates shown)
Source: SEC fails-to-deliver (CNS) data